 |
Alpha-galactosidase A |
|---|---|
| Trade Name | Replagal |
| Orphan Indication | Fabry disease |
| USA Market Approval | USA |
| USA Designation Date | 1998-06-22 00:00:00 |
| Sponsor | Shire Human Genetic Therapies, Inc.;700 Main Street;Cambridge, Massachusetts, 02139 |
Related Access Program